Clinical and Biochemical Characterization of a Patient with Congenital Disorder of Glycosylation (CDG) IIx
- 31 December 2005
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 147 (6), 851-853
- https://doi.org/10.1016/j.jpeds.2005.07.038
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporterBlood, 2005
- Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorderNature Medicine, 2004
- Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapiesEuropean Journal of Pediatrics, 2003
- Congenital disorders of glycosylation (CDG): It's all in it!Journal of Inherited Metabolic Disease, 2003
- Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)JCI Insight, 2000
- -N-Acetylgalactosamine-capping of chondroitin sulfate core region oligosaccharides primed on xylosidesGlycobiology, 1998
- A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis.Glycobiology, 1998
- Immune regulation by the ST6Gal sialyltransferaseProceedings of the National Academy of Sciences of the United States of America, 1998
- A general approach to desalting oligosaccharides released from glycoproteinsGlycoconjugate Journal, 1998
- Carbohydrate‐deficient glycoprotein syndrome type IIJournal of Inherited Metabolic Disease, 1993